自然的盾牌 - - 利用绿色空间对抗痴呆症:一个全球的元分析
Yixin Zhang1, Li Wu2, Wuji Zhao2
1International One Health Institute, Wenzhou-Kean University, Wenzhou, China; Kean University, Dorothy & George Hennings Coll Sci Math & Technol, Department of Environmental & Sustainability Science, Union, NJ, USA.
Neuroscience and biobehavioral reviews
|September 11, 2025
概括
绿色空间,特别是社区花园,为痴呆症患者提供治疗效益. 接触自然改善了社会互动,情感健康和认知功能,为老龄化人口提供了基于自然的解决方案.
科学领域:
- 环境健康 环境健康
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 痴呆症是一个日益增长的全球公共卫生挑战,特别是在老年人群中.
- 目前对痴呆症的治疗方法不足,迫切需要制定实际的预防和护理策略.
- 绿色空间为痴呆症患者提供了以自然为基础的解决方案的治疗效益.
研究的目的:
- 审查和分析绿色空间对痴呆症患者福祉的影响.
- 确定通过绿色空间影响痴呆症患者的具体好处和机制.
- 为实施城市绿地作为公共卫生干预提供证据.
主要方法:
- 对37项符合条件的研究进行了元分析和综合审查.
- 从2009年到2024年搜索六个数据库进行相关研究.
- 分析了个人能力,社交互动,心理压力和情绪健康方面的效果大小相关性.
主要成果:
- 城市绿地,特别是社区花园,对痴呆症患者和老年人有很大的好处.
- 积极的影响包括减少痴呆症发病率,改善社会参与,增强认知功能和更好的情绪健康.
- 观察到的好处包括减少焦虑,抑郁,焦虑,改善生活质量和睡眠.
结论:
- 绿色空间对痴呆症患者的心理健康和整体福祉有积极的影响.
- 实施城市绿色空间是预防和照顾痴呆症的务实方法.
- 这些以自然为基础的解决方案与老龄化人口的可持续发展目标保持一致.
相关概念视频
Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Cognitive Development During Adulthood
792
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
792
Parkinson's Disease: Treatment
995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995


